Patient-Reported Symptom and Functioning Status during the First 12 Months after Chimeric Antigen Receptor T Cell Therapy for Hematologic Malignancies.
Wang XS, Srour SA, Whisenant M, Subbiah IM, Chen TH, Ponce D, Gonzalez AG, Kamal M, Mendoza T, Cleland CS, Kebriaei P, Neelapu SS, Rezvani K, Ahmed S, Shpall E.
Wang XS, et al. Among authors: gonzalez ag.
Transplant Cell Ther. 2021 Nov;27(11):930.e1-930.e10. doi: 10.1016/j.jtct.2021.07.007. Epub 2021 Jul 12.
Transplant Cell Ther. 2021.
PMID: 34265479
Free PMC article.